In this post, we will look at what the best online casinos UK will look like in 2022 and what the largest online casinos will do. You can take advantage of our offers to filter out the bad apples from the endless selection of online casinos and focus exclusively on quality sites.
For many years media pundits have predicted the end of broadcast/cable television as both a dominant medium and as a successful seller of ad space. As a DTC information provider we at DTC Perspectives are media agnostic. We believe in DTC but do not choose one advertising medium to favor. That neutrality has us question […]
This year’s DTC Perspectives Top 25 Marketers of the Year list includes ad campaigns both old and new. In addition to the long-advertised household names such as Viagra from Pfizer and Crestor from AstraZeneca, brand managers for some up-and-coming drugs made the cut as well. Such campaigns include Jardiance from Eli Lilly, Belsomra from Merck, […]
Despite pressure from all angles for stricter limits on prescription drug ads, the industry continues to expend billions on their campaigns. Sky-high spending has been continuously increasing over the past few years; surpassing the $5 billion mark this year. It is estimated that one quarter of this $5.2B came from five campaigns: Humira, Lyrica, Eliquis, […]
Last week I wrote about the recovery in DTC spending in 2015. That should have been a happy event and one we all should have celebrated. Yet, another anti-DTC bill emerged in the Senate, sponsored by Al Franken and three other Democrats. This bill calls for ending the tax deductibility of advertising. The bill will […]
DTC spending continued its strong comeback in 2015, following a strong 2014. Spending was $5.17 billion in 2015 according to Nielsen, the best performance since 2007 when $5.33 billion was spent. Fueled by many new product launches, DTC advertisers spent heavily in 2015. Some of the biggest newer spenders were Xifaxan, Toujeo, Belsomra, Breo Ellipta, […]
New technology in the form vitamin-sized capsules, known as edible electronics, may be the future of colorectal cancer screening. Currently in development, such capsules can be swallowed and used to capture images inside the digestive tract. One design known as PillCam, from Medtronic, uses two mini-cameras that are capable of capturing 35 frames per second. What […]
With a sweeping 89-4 Senate vote, Dr. Robert M. Califf was confirmed as FDA Commissioner on Wednesday, February 24th. A cardiologist by training, Dr. Califf spent years supervising clinical trials within the pharmaceutical industry. In his interview, Califf stressed the importance of using electronic medical databases as early-warning systems to identify safety lapses of drugs […]
There are several candidates talking about the high costs of drugs. The Republican front-runner, Donald Trump, has said in his town halls that we could save $300 billion a year by negotiating pricing through competitive bidding. Bernie says drug companies make outrageous profits and through a single payer system, he would dramatically lower costs. Hillary […]
By Givi Topchishvili of 9.8 Group Let me begin by admitting that I haven’t watched a Congressional Hearing since Michael Corleone had to stare down angry lawmakers in the Godfather Part II. Little did I know how accurately a 1974 Hollywood scene portrayed the reality I saw on 2016 CSPAN airing of the Congressional Hearing […]
By Linda J. DiPersio, MSM, MSHC A recent eMarketer study projects that by the end of this year 63% of the overall digital display ad spending in the United States will be attributed to programmatic media buying – and this figure is estimated to soar towards 83% in 2017. In the pharmaceutical industry, programmatic buying […]
